APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy GMP Manufacturing Platform

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell Therapy GMP Manufacturing Platform Industry Growth and Trends Forecast to 2032

28 December 2025114 pages

Choose your research edition.

Industry ResearchCell Therapy GMP Manufacturing Platform Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy GMP Manufacturing Platform Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cell Therapy GMP Manufacturing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy GMP Manufacturing Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy GMP Manufacturing Platform Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Cell Therapy GMP Manufacturing Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Therapy GMP Manufacturing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cell Therapy GMP Manufacturing Platform market include Cellares, Miltenyi Biotec, Cytiva, Lonza, Adva Biotechnology, BioNTech, 3M, Ori Biotech and Limula, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell Therapy GMP Manufacturing Platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell Therapy GMP Manufacturing Platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Therapy GMP Manufacturing Platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Therapy GMP Manufacturing Platform.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cell Therapy GMP Manufacturing Platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell Therapy GMP Manufacturing Platform Market by Company

Cellares

Miltenyi Biotec

Cytiva

Lonza

Adva Biotechnology

BioNTech

3M

Ori Biotech

Limula

Resilience

Cellistic

Catalent

Criver

ElevateBio

Ultragenyx

Cell Therapy GMP Manufacturing Platform Segment by Type

Autologous Cell Therapy GMP Manufacturing Platform

Allogeneic Cell Therapy GMP Manufacturing Platform

Cell Therapy GMP Manufacturing Platform Segment by Application

Clinical Research

Commercial Production

Cell Therapy GMP Manufacturing Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy GMP Manufacturing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy GMP Manufacturing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy GMP Manufacturing Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cell Therapy GMP Manufacturing Platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy GMP Manufacturing Platform Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cell Therapy GMP Manufacturing Platform Market Share by Region (2021-2026) Table 4. Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cell Therapy GMP Manufacturing Platform Market Share by Region (2027-2032) Table 6. Global Cell Therapy GMP Manufacturing Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell Therapy GMP Manufacturing Platform Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2026) Table 9. Global Cell Therapy GMP Manufacturing Platform Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cell Therapy GMP Manufacturing Platform Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cell Therapy GMP Manufacturing Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cell Therapy GMP Manufacturing Platform Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2026) Table 24. Global Cell Therapy GMP Manufacturing Platform Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cell Therapy GMP Manufacturing Platform Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cell Therapy GMP Manufacturing Platform Industry Trends Table 37. Cell Therapy GMP Manufacturing Platform Industry Drivers Table 38. Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges Table 39. Cell Therapy GMP Manufacturing Platform Industry Restraints Table 40. Global Cell Therapy GMP Manufacturing Platform Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Company (2021-2026) Table 42. Global Cell Therapy GMP Manufacturing Platform Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cell Therapy GMP Manufacturing Platform Key Company Headquarters & Area Served Table 44. Global Cell Therapy GMP Manufacturing Platform Company, Product Type & Application Table 45. Global Cell Therapy GMP Manufacturing Platform Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cell Therapy GMP Manufacturing Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cellares Company Information Table 49. Cellares Business Overview Table 50. Cellares Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio Table 52. Cellares Recent Development Table 53. Miltenyi Biotec Company Information Table 54. Miltenyi Biotec Business Overview Table 55. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio Table 57. Miltenyi Biotec Recent Development Table 58. Cytiva Company Information Table 59. Cytiva Business Overview Table 60. Cytiva Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio Table 62. Cytiva Recent Development Table 63. Lonza Company Information Table 64. Lonza Business Overview Table 65. Lonza Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio Table 67. Lonza Recent Development Table 68. Adva Biotechnology Company Information Table 69. Adva Biotechnology Business Overview Table 70. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio Table 72. Adva Biotechnology Recent Development Table 73. BioNTech Company Information Table 74. BioNTech Business Overview Table 75. BioNTech Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 77. BioNTech Recent Development Table 78. 3M Company Information Table 79. 3M Business Overview Table 80. 3M Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. 3M Cell Therapy GMP Manufacturing Platform Product Portfolio Table 82. 3M Recent Development Table 83. Ori Biotech Company Information Table 84. Ori Biotech Business Overview Table 85. Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio Table 87. Ori Biotech Recent Development Table 88. Limula Company Information Table 89. Limula Business Overview Table 90. Limula Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Limula Cell Therapy GMP Manufacturing Platform Product Portfolio Table 92. Limula Recent Development Table 93. Resilience Company Information Table 94. Resilience Business Overview Table 95. Resilience Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio Table 97. Resilience Recent Development Table 98. Cellistic Company Information Table 99. Cellistic Business Overview Table 100. Cellistic Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio Table 102. Cellistic Recent Development Table 103. Catalent Company Information Table 104. Catalent Business Overview Table 105. Catalent Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio Table 107. Catalent Recent Development Table 108. Criver Company Information Table 109. Criver Business Overview Table 110. Criver Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Criver Cell Therapy GMP Manufacturing Platform Product Portfolio Table 112. Criver Recent Development Table 113. ElevateBio Company Information Table 114. ElevateBio Business Overview Table 115. ElevateBio Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio Table 117. ElevateBio Recent Development Table 118. Ultragenyx Company Information Table 119. Ultragenyx Business Overview Table 120. Ultragenyx Cell Therapy GMP Manufacturing Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio Table 122. Ultragenyx Recent Development Table 123. North America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2026) Table 126. North America Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Cell Therapy GMP Manufacturing Platform Market Share Forecast by Country (2027-2032) Table 128. Europe Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2026) Table 131. Europe Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Cell Therapy GMP Manufacturing Platform Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2026) Table 136. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Share Forecast by Country (2027-2032) Table 138. Latin America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2026) Table 141. Latin America Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Cell Therapy GMP Manufacturing Platform Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2026) Table 146. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cell Therapy GMP Manufacturing Platform Product Image Figure 3. Global Cell Therapy GMP Manufacturing Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cell Therapy GMP Manufacturing Platform Market Size (2021-2032) & (US$ Million) Figure 5. Global Cell Therapy GMP Manufacturing Platform Market Share by Region: 2025 VS 2032 Figure 6. Global Cell Therapy GMP Manufacturing Platform Market Share by Region (2021-2032) Figure 7. North America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Autologous Cell Therapy GMP Manufacturing Platform Image Figure 13. Global Autologous Cell Therapy GMP Manufacturing Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Allogeneic Cell Therapy GMP Manufacturing Platform Image Figure 15. Global Allogeneic Cell Therapy GMP Manufacturing Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cell Therapy GMP Manufacturing Platform Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cell Therapy GMP Manufacturing Platform Market Share by Type 2025 VS 2032 Figure 18. North America Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2032) Figure 19. Europe Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2032) Figure 21. Latin America Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Share by Type (2021-2032) Figure 23. Clinical Research Image Figure 24. Global Clinical Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Commercial Production Image Figure 26. Global Commercial Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Cell Therapy GMP Manufacturing Platform Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cell Therapy GMP Manufacturing Platform Market Share by Application 2025 VS 2032 Figure 29. North America Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2032) Figure 30. Europe Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2032) Figure 32. Latin America Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Cell Therapy GMP Manufacturing Platform Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Cell Therapy GMP Manufacturing Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Cell Therapy GMP Manufacturing Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2032) Figure 39. Europe Cell Therapy GMP Manufacturing Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Cell Therapy GMP Manufacturing Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2032) Figure 42. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2032) Figure 45. Latin America Cell Therapy GMP Manufacturing Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Cell Therapy GMP Manufacturing Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2032) Figure 48. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy GMP Manufacturing Platform
  • Allogeneic Cell Therapy GMP Manufacturing Platform
Applications
  • Clinical Research
  • Commercial Production
Companies covered
  • Cellares
  • Miltenyi Biotec
  • Cytiva
  • Lonza
  • Adva Biotechnology
  • BioNTech
  • 3M
  • Ori Biotech
  • Limula
  • Resilience
  • Cellistic
  • Catalent
  • Criver
  • ElevateBio
  • Ultragenyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cell Therapy GMP Manufacturing Platform Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2021-2032)
  5. 1.4.1 Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2021-2026)
  6. 1.4.2 Global Cell Therapy GMP Manufacturing Platform Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
  8. 1.5.1 North America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (2021-2032)
2 Cell Therapy GMP Manufacturing Platform Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Autologous Cell Therapy GMP Manufacturing Platform
  3. 2.1.2 Allogeneic Cell Therapy GMP Manufacturing Platform
  4. 2.2 Global Cell Therapy GMP Manufacturing Platform Market Size by Type
  5. 2.2.1 Global Cell Therapy GMP Manufacturing Platform Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cell Therapy GMP Manufacturing Platform Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cell Therapy GMP Manufacturing Platform Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cell Therapy GMP Manufacturing Platform Market Size by Regions
  9. 2.3.1 North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Type (2021-2026)
3 Cell Therapy GMP Manufacturing Platform Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinical Research
  3. 3.1.2 Commercial Production
  4. 3.2 Global Cell Therapy GMP Manufacturing Platform Market Size by Application
  5. 3.2.1 Global Cell Therapy GMP Manufacturing Platform Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Cell Therapy GMP Manufacturing Platform Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Cell Therapy GMP Manufacturing Platform Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Cell Therapy GMP Manufacturing Platform Market Size by Regions
  9. 3.3.1 North America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Cell Therapy GMP Manufacturing Platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cell Therapy GMP Manufacturing Platform Industry Trends
  2. 4.2 Cell Therapy GMP Manufacturing Platform Industry Drivers
  3. 4.3 Cell Therapy GMP Manufacturing Platform Industry Opportunities and Challenges
  4. 4.4 Cell Therapy GMP Manufacturing Platform Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cell Therapy GMP Manufacturing Platform Revenue (2021-2026)
  2. 5.2 Global Cell Therapy GMP Manufacturing Platform Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cell Therapy GMP Manufacturing Platform Key Company Headquarters & Area Served
  4. 5.4 Global Cell Therapy GMP Manufacturing Platform Company, Product Type & Application
  5. 5.5 Global Cell Therapy GMP Manufacturing Platform Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cell Therapy GMP Manufacturing Platform Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cell Therapy GMP Manufacturing Platform Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cell Therapy GMP Manufacturing Platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cellares
  2. 6.1.1 Cellares Company Information
  3. 6.1.2 Cellares Business Overview
  4. 6.1.3 Cellares Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio
  6. 6.1.5 Cellares Recent Developments
  7. 6.2 Miltenyi Biotec
  8. 6.2.1 Miltenyi Biotec Company Information
  9. 6.2.2 Miltenyi Biotec Business Overview
  10. 6.2.3 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio
  12. 6.2.5 Miltenyi Biotec Recent Developments
  13. 6.3 Cytiva
  14. 6.3.1 Cytiva Company Information
  15. 6.3.2 Cytiva Business Overview
  16. 6.3.3 Cytiva Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio
  18. 6.3.5 Cytiva Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Adva Biotechnology
  26. 6.5.1 Adva Biotechnology Company Information
  27. 6.5.2 Adva Biotechnology Business Overview
  28. 6.5.3 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio
  30. 6.5.5 Adva Biotechnology Recent Developments
  31. 6.6 BioNTech
  32. 6.6.1 BioNTech Company Information
  33. 6.6.2 BioNTech Business Overview
  34. 6.6.3 BioNTech Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio
  36. 6.6.5 BioNTech Recent Developments
  37. 6.7 3M
  38. 6.7.1 3M Company Information
  39. 6.7.2 3M Business Overview
  40. 6.7.3 3M Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 3M Cell Therapy GMP Manufacturing Platform Product Portfolio
  42. 6.7.5 3M Recent Developments
  43. 6.8 Ori Biotech
  44. 6.8.1 Ori Biotech Company Information
  45. 6.8.2 Ori Biotech Business Overview
  46. 6.8.3 Ori Biotech Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio
  48. 6.8.5 Ori Biotech Recent Developments
  49. 6.9 Limula
  50. 6.9.1 Limula Company Information
  51. 6.9.2 Limula Business Overview
  52. 6.9.3 Limula Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Limula Cell Therapy GMP Manufacturing Platform Product Portfolio
  54. 6.9.5 Limula Recent Developments
  55. 6.10 Resilience
  56. 6.10.1 Resilience Company Information
  57. 6.10.2 Resilience Business Overview
  58. 6.10.3 Resilience Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio
  60. 6.10.5 Resilience Recent Developments
  61. 6.11 Cellistic
  62. 6.11.1 Cellistic Company Information
  63. 6.11.2 Cellistic Business Overview
  64. 6.11.3 Cellistic Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio
  66. 6.11.5 Cellistic Recent Developments
  67. 6.12 Catalent
  68. 6.12.1 Catalent Company Information
  69. 6.12.2 Catalent Business Overview
  70. 6.12.3 Catalent Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio
  72. 6.12.5 Catalent Recent Developments
  73. 6.13 Criver
  74. 6.13.1 Criver Company Information
  75. 6.13.2 Criver Business Overview
  76. 6.13.3 Criver Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Criver Cell Therapy GMP Manufacturing Platform Product Portfolio
  78. 6.13.5 Criver Recent Developments
  79. 6.14 ElevateBio
  80. 6.14.1 ElevateBio Company Information
  81. 6.14.2 ElevateBio Business Overview
  82. 6.14.3 ElevateBio Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio
  84. 6.14.5 ElevateBio Recent Developments
  85. 6.15 Ultragenyx
  86. 6.15.1 Ultragenyx Company Information
  87. 6.15.2 Ultragenyx Business Overview
  88. 6.15.3 Ultragenyx Cell Therapy GMP Manufacturing Platform Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio
  90. 6.15.5 Ultragenyx Recent Developments
7 North America
  1. 7.1 North America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
  3. 7.3 North America Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
  3. 8.3 Europe Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
  3. 10.3 South America Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst